Skip to content

OMAD'S LAB

Active Private limited companyfounded 2024active for 2 yearsRue du Polissou 38, 5590 CineyKBO/BCE: BE 1013.686.127

Lifetime

2 annual accounts with figures on one time axis
peak of €20,863 in 2025
€20,863▲ €23,743
lowest -€2,888 in 2024
€14,627▲ €17,515
peak of €13,073 in 2025
€13,073▲ 117×
€24,642▲ 756%
Board2 names since 2024
2 directors and 1 other
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Gross margin from -€2,880 to €20,863Profit of €14,627, after a lossDividend €1,666Equity from €112 to €13,073Debts from €2,880 to €24,642Cash from €2,991 to €5,953

Key points

from the 2025 annual accounts

Equity

€13,073 ▲ 117×
1122024+14,627Profit-1,666Dividend13,0732025

OMAD'S LAB paid out €1,666 in dividends. That is 11% of the 2025 profit.

Turnover

≈ €160,000 estimated

The micro format states no turnover.

Investments

€8,732 13.6 times depreciation

Green is investment, beige is depreciation.

2025 accounts filed 61 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as OMAD'S LAB has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for OMAD'S LAB. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 50 sharesdeed of 19-09-2024
  • 50 sharesdeed of 19-09-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1013686127
Incorporation Founding capital of €3,000, 100 shares · Founded by and · (director) and (director) appointed · published on 19-09-2024 · Gazette deed
First establishment Rue du Polissou 38, Ciney
All 6 events

Comparable companies

same main activity, similar in size and age
Company
OMAD'S LAB Ciney €37,716 €20,863 34.7% -
Chrometra Scientific Kortenaken €72,995 €7,007 27.4% -
Maria De Dauw Antwerp €9,095 €3,168 35.3% -
FCT ASSEMBLY EUROPE Veurne €167,465 €3,345 6.9% -
ADVANCED CONSTRUCTION CHEMICALS Antwerp €311,417 €65,719 8.0% -
Heatcover Stekene €62,446 €4,484 36.4% -
Healant Zaventem €34,146 €147 3.8% -

These companies have the same main activity as OMAD'S LAB: manufacture of chemicals and chemical products (NACE 20590). They are comparable in size and age: total assets between €9,090 and €311,000, founded between 2019 and 2024.

Official details

Source: KBO
Status
Active since 17-09-2024Normal situation
Registered office
12 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Manufacture of chemicals and chemical productsNACE 20590and 2 others
Establishment unit
2.367.788.1135590 Ciney, since 17-09-2024
Financial year end
31 December
Peppol
Reachable since 19-12-2025
Company details

Annual accounts 2025

€37,716▲ 13×
Filing
Filed on 30-09-2026
Financials

Insights on OMAD'S LAB

The 2025 annual accounts show equity of €13,073 and a net result of €14,627. Its solvency ranks better than 60% of 166 sector peers (NACE 20) in financial year 2025.

The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about OMAD'S LAB

What is the company number of OMAD'S LAB?
The company number of OMAD'S LAB is 1013.686.127. The VAT number is the same number with BE in front: BE 1013.686.127.
Where is OMAD'S LAB based?
The registered office is at Rue du Polissou 38, 5590 Ciney.Company details
What does OMAD'S LAB do?
According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20590).
What is the legal form of OMAD'S LAB?
OMAD'S LAB is a private limited company (BV).
When was OMAD'S LAB founded?
OMAD'S LAB was founded on 17-09-2024.
Is OMAD'S LAB still active?
Yes, OMAD'S LAB is an active enterprise in the KBO register.
What is the turnover of OMAD'S LAB?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €20,863 and 7,101 comparable companies of the same size. It probably lies between €71,000 and €370,000. It is a rough estimate.Financials
Is OMAD'S LAB profitable?
In financial year 2025, OMAD'S LAB made a profit of €14,627.
Where can I find the annual accounts of OMAD'S LAB?
OMAD'S LAB filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of OMAD'S LAB due?
OMAD'S LAB must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.